CompletedPhase 3NCT00803062
Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
Studying Adenocarcinoma of the cervix uteri
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Cancer Institute (NCI)
- Principal Investigator
- Krishnansu Tewari, M.DNRG Oncology
- Intervention
- Bevacizumab(biological)
- Enrollment
- 452 enrolled
- Eligibility
- 18 years · FEMALE
- Timeline
- 2009 – 2013
Study locations (30)
- University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute, Mobile, Alabama, United States
- Saint Joseph's Hospital and Medical Center, Phoenix, Arizona, United States
- Highlands Oncology Group PA - Fayetteville, Fayetteville, Arkansas, United States
- Washington Regional Medical Center - Fayetteville, Fayetteville, Arkansas, United States
- University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
- Alta Bates Summit Medical Center-Herrick Campus, Berkeley, California, United States
- Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank, California, United States
- Roy and Patricia Disney Family Cancer Center, Burbank, California, United States
- Mills - Peninsula Hospitals, Burlingame, California, United States
- John Muir Medical Center-Concord Campus, Concord, California, United States
- City of Hope Comprehensive Cancer Center, Duarte, California, United States
- California Cancer Center - North Fresno, Fresno, California, United States
- Long Beach Memorial Medical Center-Todd Cancer Institute, Long Beach, California, United States
- Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
NRG Oncology
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00803062 on ClinicalTrials.govOther trials for Adenocarcinoma of the cervix uteri
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07276360Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in UgandaUganda Cancer Institute
- RECRUITINGPHASE1NCT07454642AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid TumorsAvacta Life Sciences Ltd
- RECRUITINGPHASE3NCT07061977Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical CancerNational Cancer Institute (NCI)
- RECRUITINGNCT07359586Laryngopharyngeal Injury After Endotracheal Intubation Under General AnesthesiaZhejiang University
- RECRUITINGPHASE1NCT07020117A Study of [225Ac]Ac-AKY-1189 in Patients With Solid TumorsAktis Oncology, Inc.
- RECRUITINGPHASE2NCT06654011IN10018 With Nab-Paclitaxel and Cadonilimab for Metastatic or Recurrent Gastric-Type Cervical Adenocarcinoma: Phase 2 TrialUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT07153952RT for Adenocarcinoma/Adenosquamous CarcinomaPeking Union Medical College Hospital
- RECRUITINGNCT06733740Ultrasound-guided Thermal Ablation for Papillary Thyroid CarcinomaChinese PLA General Hospital